Conference Coverage

AHA 2023

Philadelphia, Pennsylvania

November 11, 2023

November 13, 2023

News Conference News AHA 2023

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

(UPDATED) In patients not taking antianginal meds, PCI clearly alleviated some—but not all—symptoms. What does that mean in practice?

More News

News Conference News AHA 2023

DAPA-MI: Cardiometabolic Endpoints ‘Win’ With Dapagliflozin After Acute MI

Shelley Wood

November 11, 2023

News Conference News AHA 2023

Full SELECT Results Affirm CV Risk Reduction With Semaglutide in Nondiabetics

Todd Neale

November 11, 2023

News Conference News AHA 2023

AZALEA-TIMI 71: Bleeds Plunge With Abelacimab vs Rivaroxaban in AF, but Stroke Impact Unclear

L.A. McKeown

November 12, 2023

News Conference News AHA 2023

ARTESiA: Apixaban Lowers Stroke Risk in Subclinical AF

Todd Neale

November 12, 2023

News Conference News AHA 2023

DAPA-MI: Cardiometabolic Endpoints ‘Win’ With Dapagliflozin After Acute MI

Shelley Wood

November 11, 2023

More Slides

Presentation AHA 2023

Physician Optimised Postpartum Hypertension Treatment (POP-HT) Randomised Trial

Presenter: Jamie Kitt

November 17, 2023

Presentation AHA 2023

Effects of intensive blood pressure lowering treatment in reducing risk of cardiovascular events

Presenter: Jing Li

November 16, 2023

Presentation AHA 2023

AZALEA-TIMI 71

Presenter: Christian T. Ruff

November 15, 2023

Presentation AHA 2023

Validation of a Speech Analysis Application to Detect Worsening Heart Failure Events in Ambulatory Heart Failure Patients

Presenter: William T. Abraham

November 15, 2023

AHA 2023 Wrap-Up

See More Videos

Podcasts

Podcast Rox Heart Radio

Rox Heart Radio: AHA 2023

November 08, 2023

All Conference Content

Advertisement

AHA 2023

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

More News

DAPA-MI: Cardiometabolic Endpoints ‘Win’ With Dapagliflozin After Acute MI

Full SELECT Results Affirm CV Risk Reduction With Semaglutide in Nondiabetics

AZALEA-TIMI 71: Bleeds Plunge With Abelacimab vs Rivaroxaban in AF, but Stroke Impact Unclear

ARTESiA: Apixaban Lowers Stroke Risk in Subclinical AF

DAPA-MI: Cardiometabolic Endpoints ‘Win’ With Dapagliflozin After Acute MI

More Slides

Physician Optimised Postpartum Hypertension Treatment (POP-HT) Randomised Trial

Effects of intensive blood pressure lowering treatment in reducing risk of cardiovascular events

AZALEA-TIMI 71

Validation of a Speech Analysis Application to Detect Worsening Heart Failure Events in Ambulatory Heart Failure Patients

AHA 2023 Wrap-Up

Podcasts

Rox Heart Radio: AHA 2023

Advertisement

All Conference Content

Advertisement

AHA 2023

More News

More Slides

Podcasts

Advertisement

All Conference Content

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content

AHA 2023